PRTA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Prothena Corporation PLC (PRTA) is not a strong buy at the moment for a beginner investor with a long-term focus. The lack of significant positive catalysts, poor financial performance in the latest quarter, and absence of strong trading signals suggest that holding off on this investment is prudent for now.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), a slightly positive MACD histogram (0.011), and a neutral RSI (59.696). Key resistance levels are at 10.976 and 11.186, while support levels are at 10.296 and 10.086. However, the stock's candlestick pattern suggests a 50% chance of a -1.61% decline in the next day and a -2.4% decline in the next week.
Bullish moving averages and a slightly positive MACD histogram. Gross margin remains at 100%, showcasing operational efficiency.
Severe declines in revenue (-99.01% YoY), net income (-62.75% YoY), and EPS (-62.96% YoY) in the latest quarter (2025/Q4). No recent news or significant insider or hedge fund activity. No recent congress trading data. Stock trend analysis indicates potential short-term declines.
In 2025/Q4, revenue dropped significantly to 21,000 (-99.01% YoY), net income fell to -21,589,000 (-62.75% YoY), and EPS dropped to -0.4 (-62.96% YoY). Gross margin remained at 100%, unchanged YoY.
No data on recent analyst ratings or price target changes.
